Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective
2015 Standout
Understanding effective treatments of myofascial trigger points
2002
A systematic review of LDL apheresis in the treatment of cardiovascular disease
2006
Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis
2004
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Effectiveness of Dry Needling for Upper-Quarter Myofascial Pain: A Systematic Review and Meta-analysis
2013 Standout
Ototoxicity: therapeutic opportunities
2005
Mechanisms of cisplatin-induced ototoxicity and prevention
2006
Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points
1998 Standout
Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial
2008
State of the Art of Low‐density Lipoprotein Apheresis in the Year 2003
2004
Genetic basis for individual variations in pain perception and the development of a chronic pain condition
2004 Standout
Dry Needling to a Key Myofascial Trigger Point May Reduce the Irritability of Satellite MTrPs
2007 Standout
The use of unequal randomisation ratios in clinical trials: A review
2005
Apheresis for idiopathic sudden hearing loss: Reviewing the evidence
2006
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Nociception from skeletal muscle in relation to clinical muscle pain
1993
Rheopheresis: Rheologic, Functional, and Structural Aspects
2000
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
1997
Heparin‐induced Extracorporeal Low‐density Lipoprotein Precipitation
2003
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients
2009
What’s going on in LDL apheresis
2007
Acute Effect of Rheopheresis on Peripheral Endothelial Dysfunction in Patients Suffering From Sudden Hearing Loss
2005
Molecular mechanisms of cisplatin resistance
2011 Standout
The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial
2015
Acupuncture Therapy for Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2015
Recent advances in therapeutic apheresis
2003
Myofascial pain
2002 Standout
Sudden sensorineural hearing loss: An autoimmune disease?
2011
Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine
2003
Inner ear drug delivery for auditory applications
2008
Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to myofascial pain syndrome
2008 Standout
Evidence-Based Practice
2012
Reliability of Physical Examination for Diagnosis of Myofascial Trigger Points
2008 Standout
The effect of dry needling on pain, pressure pain threshold and disability in patients with a myofascial trigger point in the upper trapezius muscle
2013
Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL)
2014
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
2001 Standout
An expansion of Simons’ integrated hypothesis of trigger point formation
2004
Effect of high dose intravenous vitamin C on idiopathic sudden sensorineural hearing loss: a prospective single-blind randomized controlled trial
2012
Quality of Life in Patients With Idiopathic Sudden Hearing Loss
2008
Cisplatin: The first metal based anticancer drug
2019 Standout
Rheopheresis for sudden sensorineural hearing loss
2009
Dry needling: a literature review with implications for clinical practice guidelines
2013 Standout
Myofascial Trigger Points
2007 Standout
Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
2005 StandoutNobel
Treatment with HELP‐apheresis in patients suffering from sudden sensorineural hearing loss: A prospective, randomized, controlled study
2010
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
2017
Biochemicals Associated With Pain and Inflammation are Elevated in Sites Near to and Remote From Active Myofascial Trigger Points
2008 Standout
Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
2010
Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction
2003 Standout
International Consensus on Diagnostic Criteria and Clinical Considerations of Myofascial Trigger Points: A Delphi Study
2017 Standout
The influence of cholesterol on the motility of cochlear outer hair cells and the motor protein prestin
2009
Effectiveness of Dry Needling for Myofascial Trigger Points Associated With Neck and Shoulder Pain: A Systematic Review and Meta-Analysis
2015 Standout
The HELP System for the Treatment of Atherothrombotic Disorders: A Review
2003
Pathophysiology of upper extremity muscle disorders
2005 Standout
Bone-Conducted Sound: Physiological and Clinical Aspects
2005 Standout
Does a Reduction of Adhesion Molecules by LDL‐Apheresis Have a Role in the Treatment of Sudden Hearing Loss?
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale
2012
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy
2017
Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies
2009
Statins for the primary prevention of cardiovascular disease
2013
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Intratympanic steroids as a salvage treatment for sudden sensorineural hearing loss? A meta-analysis
2014
Current Research on Myofascial Trigger Points–Pathophysiological Studies
1999
Neural Stimulation and Recording Electrodes
2008 Standout
Administration of substances to laboratory animals: routes of administration and factors to consider.
2011 Standout
Myofascial Trigger Points: Pathophysiology and Correlation with Acupuncture Points
2000
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Apheresis as Rescue Therapy in a Severe Case of Sudden Hearing Loss
2011
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Myofascial Trigger Points: An Evidence-Informed Review
2006
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
2017
Neurotrophic Factors and Neural Prostheses: Potential Clinical Applications Based Upon Findings in the Auditory System
2007
Myofascial Trigger Points: The Critical Experiment
1997
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Diagnostic Criteria of Myofascial Pain Caused by Trigger Points
1999
Isolated Congenital round Window Absence
2002
Works of M. Suckfüll being referenced
Round Window Application of D-Methionine, Sodium Thiosulfate, Brain-Derived Neurotrophic Factor, and Fibroblast Growth Factor-2 in Cisplatin-Induced Ototoxicity
2004
Hyperfibrinogenemia as a Risk Factor for Sudden Hearing Loss
2002
Evaluation of the middle and inner ear structures: comparison of hybrid rendering, virtual endoscopy and axial 2D source images
1999
Hypercholesterinämie und Hyperfibrinogenämie beim Hörsturz*
1997
Effect of Atorvastatin on Progression of Sensorineural Hearing Loss and Tinnitus in the Elderly
2007
Heparin-induced extracorporal low-density-lipoprotein precipitation (H. E. L. P.) to improve the recovery of hearing in patients with sudden idiopathic hearing loss
2000
Perspectives on the Pathophysiology and Treatment of Sudden Idiopathic Sensorineural Hearing Loss
2009
Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial
2002
Heparin‐Induced Extracorporeal Low‐Density Lipoprotein Precipitation Apheresis: A New Therapeutic Concept in the Treatment of Sudden Hearing Loss
2001
[The incidence of sudden hearing loss is greater than previously assumed].
2005
Evolutionary and immunological aspects of xenotransplantation.
1992
[Tissue pO2 measurement in taut back musculature (m. erector spinae)].
1990